Vital Farms, Inc. — FY2023 Form 10-K
Business context and reporting period. Vital Farms sells pasture-raised shell eggs and related products, butter and other foods through retail and foodservice channels. Its fiscal year ended December 31, 2023, comprised 53 weeks, compared with 52 weeks in FY2022; this filing reports annual results, not standalone fourth-quarter results. The company sourced eggs from more than 300 family farms and sold through approximately 24,000 stores.
Key financial results
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net revenue | $471.9 million | $362.1 million |
| Gross profit / gross margin | $162.3 million / 34% | $109.4 million / 30% |
| Operating income / margin | $33.3 million / 7% | $2.1 million / 1% |
| Net income | $25.6 million | $1.2 million |
| Diluted EPS | $0.59 | $0.03 |
| Adjusted EBITDA (non-GAAP) | $48.3 million | $16.2 million |
| Cash from operating activities | $50.9 million | $(8.1) million |
Revenue grew 30%; management attributed $59.4 million of the increase to pricing and $50.5 million to volume, including growth at new and existing customers. The extra fiscal week contributed $8.5 million, or 2.3%, to growth; excluding it, revenue increased 28%. Eggs and egg-related products generated $449.0 million, approximately 95% of revenue. Gross-margin improvement reflected volume growth and January 2023 shell-egg price increases, which helped offset higher commodity, packaging and labor costs. SG&A rose 32% to $101.7 million, primarily due to marketing and employee costs; shipping and distribution expense fell 9% to $27.3 million.
Liquidity, cash flow and debt
- At year-end, cash and cash equivalents were $84.1 million and available-for-sale securities were $32.7 million, totaling $116.8 million. The company also had $20.0 million of revolving credit capacity available and reported no revolver balance at year-end.
- Cash from investing activities was $22.4 million, primarily reflecting maturities of investment securities; purchases of property, plant and equipment were $11.5 million. Financing activities used $2.1 million, mainly for finance-lease principal payments.
- Total liabilities were $82.5 million. Finance-lease liabilities totaled $13.7 million; operating-lease liabilities totaled $8.8 million. The PNC facility matures April 2, 2025, is secured by substantially all assets and has financial and other covenants. The company reported compliance with covenants at year-end.
Outlook, commentary and notable risks
- Management expects available cash, securities, operating cash flows and credit capacity to fund operations for at least the next 12 months. It anticipates approximately $10 million of FY2024 capital expenditures related to a potential additional egg-packing facility, including spending initially planned for FY2023, and expects higher marketing spending.
- Higher construction costs for new farms are expected to require $10 million to $12 million of upfront working capital during FY2024. Management expects these costs to be recognized over the related four-to-five-year supply contracts and says their gross-margin impact should be immaterial over those terms.
- Management said supply of products, packaging and freight was expected to be adequate through FY2024, while noting that raw-material market volatility could affect butter supply as capacity ramps with a new supplier. The filing references updated long-term financial targets announced in September 2023 but does not provide their figures in the supplied text; it gives no clear formal FY2024 revenue or earnings guidance.
- Avian influenza outbreaks occurred at four farms; the company reported no material supply disruption to date but warned that broader outbreaks or regulatory responses could affect supply and results. Other key exposures include feed and packaging costs, premium-price sensitivity, dependence on shell eggs, customer and distributor concentration, reliance on Egg Central Station and sole-source egg-carton supply, and limited co-manufacturing capacity.
- Commodity derivative losses contributed to $2.8 million of other expense in FY2023. The company reported a continuing putative false-advertising class action; it believes the claims are without merit but cannot reasonably estimate a possible loss or range. No loss-contingency reserve was recorded. The company discontinued ghee and spreadable tub butter offerings in FY2023; related charges were immaterial.
- The independent auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective; the auditor did not attest to internal control effectiveness because of the company’s emerging-growth-company exemption.
Important facts for investors to verify
- Whether revenue growth, pricing and volume trends continue, and whether improved gross margin converts into sustained GAAP profitability and operating cash flow.
- How the planned FY2024 farm recruitment outlays, packing-facility capital spending and higher marketing investment affect working capital and returns.
- Egg and feed availability, avian-influenza developments, butter supply, packaging costs and the company’s ability to pass cost increases through to customers without weakening demand.
- Exposure to major customers and distributors: the filing reports UNFI at approximately 25% of FY2023 net revenue and Whole Foods at approximately 23% of retail sales; these are different measures.
- Progress and potential financial impact of the false-advertising litigation, commodity hedging, finance leases and the next egg-packing facility.